NRBF2P3

Across TCGA pan-cancer cohorts, NRBF2P3 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated NRBF2P3 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher NRBF2P3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated NRBF2P3 expression acts as an unfavorable survival marker, although some lineages such as UCS and ESCA show a favorable association.

KIRC, UCS, and CESC are the cancer types where NRBF2P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.170	0.429	.001	67	view →
UCS	OS	Tertile	II,III,IV	0.787	0.229	.001	50	view →
CESC	DFS	Quartile	II,III,IV	0.589	0.818	.001	44	view →
STAD	OS	Quartile	II,III,IV	0.429	0.818	<.001	30	view →
CHOL	DFS	Tertile	IV	0.082	0.753	.008	27	view →
MESO	DFS	Quartile	All	0.195	0.418	<.001	21	view →
UVM	DFS	Quartile	All	0.347	0.793	.013	17	view →
KIRP	DFS	Quartile	III,IV	0.429	0.800	.003	16	view →
LUAD	OS	Tertile	All	0.184	0.411	.001	14	view →
ESCA	OS	Median	IV	0.698	0.222	.006	12	view →
SARC	DFS	Quartile	All	0.153	0.370	.004	10	view →
DLBC	DFS	Median	All	0.416	0.922	.013	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

NRBF2P3–KIRC (DFS)

Open the KIRC breakdown →